Singular Genomics Systems Price Prediction

Intrinsic Valuation Low Real High 17.25 17.25 22.01 Details

Naive Forecast Low Next High 20.30 20.30 20.30 Details

Bollinger Band Projection (param) Lower Middle Band Upper 19.93 19.99 20.05 Details

Singular Genomics After-Hype Price Prediction Density Analysis

Singular Genomics Estimiated After-Hype Price Volatility

Singular Genomics Stock Price Prediction Analysis

Singular Genomics Hype Timeline

Singular Genomics Systems is now traded for 20.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Singular is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Singular Genomics is about 0.0%, with the expected price after the next announcement by competition of 20.01. About 14.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.41. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Singular Genomics Systems recorded a loss per share of 34.68. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 26th of June 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 18 days. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Singular Genomics Related Hype Analysis

Singular Genomics Additional Predictive Modules

Most predictive techniques to examine Singular price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Singular using various technical indicators. When you analyze Singular charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Singular Genomics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Singular Genomics Systems, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Singular Genomics based on analysis of Singular Genomics hews, social hype, general headline patterns, and widely used predictive technical indicators.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

If you are still planning to invest in Singular Genomics Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Singular Genomics' history and understand the potential risks before investing.